Searched for
DIAGNOSTIC STOCKS
JM Financial calls Metropolis Healthcare ‘best-value diagnostic stock’, sees up to 27% upsideJM Financial has retained its Buy rating on Metropolis Healthcare with a target price of Rs 734, implying 27.2% upside. The brokerage calls...- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsEven if the ongoing conflict in the Gulf settles anytime soon (and we certainly hope it does), don’t be surprised if the Nifty and Sensex r...
- Yatharth Hospitals draws interest from Aster, Advent as healthcare consolidation heats upAster DM Quality Care is negotiating to acquire a controlling stake in Yatharth Hospitals. This potential acquisition aims to consolidate t...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- ETMarkets Smart Talk | Two-year market consolidation may set stage for next bull run: UTI AMC’s Ajay TyagiTyagi, however, remains cautious on pockets of the mid- and small-cap universe, where valuations are above long-term averages. He sees larg...
- Corporates urge employees to stay alert as H1N1 cases surgeH1N1 cases have increased significantly, and monsoon fevers are at seasonal highs. Companies are issuing safety guidelines and advising emp...
- For investors who can hold stocks for 1 to 2 years: 6 mid-cap stocks from different sectors with an upside potential up to 21%The markets have been uncomfortable for some months now, with troubles originating largely from outside the country. Higher crude prices be...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Long-term investing: One reason is good enough, and a must, to own a business. 8 stocks with an upside potential of up to 36%In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...
- Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%Given current market conditions, better stick with stocks that offer some comfort. It could be valuation, or growth purely dependent on dom...
- Pharmeasy-parent’s loss narrows in Q1, revenue up 10%API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while reven...
- Credent Connect shares make strong market debut, list at 90% premium over IPO price on NSE SME platformCredent Connect N Care shares made a blockbuster debut on the NSE SME platform, listing at a 90% premium over the IPO price. The Rs 93.90-c...
- Strong IPO gains stoke FOMO fears, set grey market abuzzThe unofficial grey market shows increased activity with rising share prices. Recent strong IPO listings have boosted investor confidence a...
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...
- For investors with ability to ignore short-term volatility: 5 mid-cap stocks from different sectors with upside potential up to 19%Most of what impacts the market these days comes from outside the country: Oil price spikes, tariff threats, FII pull out. There is, howeve...
- Molbio Diagnostics shares rally 6% after strong debut. What should investors do?Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics le...
- Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSEMolbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 8...
- Thyrocare shares crack 8% as promoter Docon Technologies sells 10% stakeThyrocare Technologies shares fell after promoter Docon Technologies sold around 1.58 crore shares, cutting its stake from 60.92% to 51.02%...
- Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check statusMolbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market pre...
- Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as...
Load More
